Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 2
2002 4
2003 4
2004 3
2005 1
2006 1
2007 2
2008 5
2009 4
2010 4
2011 3
2012 2
2013 8
2014 8
2015 5
2016 8
2017 16
2018 24
2019 8
2020 26
2021 11
2022 16
2023 13
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS.
de Stefano N, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Hodgkinson S, Prat A, Leocani L, Schmierer K, Sellebjerg F, Vermersch P, Wiendl H, Keller B, Roy S; MAGNIFY-MS Study Group. de Stefano N, et al. Among authors: schmierer k. Neurol Neuroimmunol Neuroinflamm. 2022 Jun 14;9(4):e1187. doi: 10.1212/NXI.0000000000001187. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35701185 Free PMC article.
MS care: integrating advanced therapies and holistic management.
Giovannoni G, Ford HL, Schmierer K, Middleton R, Stennett AM, Pomeroy I, Fisniku L, Scalfari A, Bannon C, Stross R, Hughes S, Williams A, Josephs S, Peel C, Straukiene A. Giovannoni G, et al. Among authors: schmierer k. Front Neurol. 2024 Jan 30;14:1286122. doi: 10.3389/fneur.2023.1286122. eCollection 2023. Front Neurol. 2024. PMID: 38351950 Free PMC article. Review.
Anaesthetic management of people with multiple sclerosis.
Dubuisson N, de Maere d'Aertrijcke O, Marta M, Gnanapavan S, Turner B, Baker D, Schmierer K, Giovannoni G, Verma V, Docquier MA. Dubuisson N, et al. Among authors: schmierer k. Mult Scler Relat Disord. 2023 Dec;80:105045. doi: 10.1016/j.msard.2023.105045. Epub 2023 Oct 11. Mult Scler Relat Disord. 2023. PMID: 37866022 Free article. Review.
e-Health and multiple sclerosis: An update.
Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S. Lavorgna L, et al. Among authors: schmierer k. Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19. Mult Scler. 2018. PMID: 30231004 Review.
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
Allen-Philbey K, De Trane S, MacDougall A, Adams A, Bianchi L, Campion T, Giovannoni G, Gnanapavan S, Holden DW, Marta M, Mathews J, Turner BP, Baker D, Schmierer K. Allen-Philbey K, et al. Among authors: schmierer k. Ther Adv Neurol Disord. 2023 Nov 10;16:17562864231200627. doi: 10.1177/17562864231200627. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37954917 Free PMC article.
Protecting people with multiple sclerosis through vaccination.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G. Reyes S, et al. Among authors: schmierer k. Pract Neurol. 2020 Dec;20(6):435-445. doi: 10.1136/practneurol-2020-002527. Epub 2020 Jul 6. Pract Neurol. 2020. PMID: 32632038 Review.
Diffuse cerebral angiomatosis.
Schreiber SJ, Doepp F, Bender A, Schmierer K, Valdueza JM. Schreiber SJ, et al. Among authors: schmierer k. Neurology. 2003 Apr 8;60(7):1216-8. doi: 10.1212/01.wnl.0000055923.78277.9c. Neurology. 2003. PMID: 12682345 No abstract available.
160 results